AimVion A/S: Financial statements 2020
CVR: 37120618
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
AimVion A/S (CVR 37120618) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -2,211,663 and a net result of DKK -2,143,862 compared with DKK -1,758,426 the year before. Equity in the 2020 report amounted to DKK 2,697,281. The solvency ratio was 92.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -2,211,663
- Profit/Loss
- DKK -2,143,862
- Equity
- DKK 2,697,281
- Total Assets
- DKK 2,913,470
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -2.2 mio. | -2.1 mio. | 2.7 mio. | 1 |
| 2019 | - | -1.1 mio. | -1.8 mio. | 4.8 mio. | 1 |
| 2018 | - | -924 t. | -1.5 mio. | 1.1 mio. | 1 |
| 2017 | - | -1.1 mio. | -1.4 mio. | 2.1 mio. | 1 |
Official annual report
How creditworthy is AimVion A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
AimVion A/S has published its annual report for 2019. Gross profit came to DKK -1,124,889, and the net result was DKK -1,758,426.
As of March 15, 2020, Shervin Bahrami has stepped down as director of AimVion A/S.
As of February 4, 2020, Christian Gunni Pedersen is registered as director of AimVion A/S.
About AimVion A/S
AimVion A/S was a Danish company of the type Aktieselskab based in Aarhus C, founded in 2015. The company has been dissolved on 28 June 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named StemGuard A/S and StemGuard ApS. The company has 1 employee (2020). In 2021, the company reported a gross profit of DKK -2,119,220 and a net result of DKK -1,734,826 compared with DKK -2,143,862 the year before. Equity in the 2021 report amounted to DKK 962,455.